Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
Clinical trial NCT06507683 · RECRUITING
Trial details
- NCT number
- NCT06507683
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2027-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.